CORONARY ARTERY DISEASE - NEWER DIMENSIONS

Discusses metabolic factors associated with atherogenesis, the relevance of lipo-protein analysis, the role of diabetes mellitus and abnormal glucose tolerance, and the value and pitfalls of history taking. Presents three therapy considerations--myocardial revascularization, beta adrenergic blockade, and the management of lipid and carbohydrate disturbances. By Richard Gorlin, MD, Peter Bent Brigham Hospital, George F Cahill, MD, Elliott P Joslin Laboratory, Diabetes Foundation, Inc, Deaconess Hospital, and Warren J Taylor, MD, and Harvey G Kemp, MD, Harvard Medical School. (Kinescope)